Site Map

Home

• Home
• About Us
  • Company Overview
  • Company Values
  • Board of Directors
  • Management
  • Corporate Directory
• Product development
  • Product Development Pipeline
  • The science behind Neuren's products
  • Trofinetide (also known as NNZ-2566) in Rett Syndrome
  • Trofinetide (also known as NNZ-2566) in Fragile X Syndrome
  • NNZ-2591 in Phelan-McDermid syndrome
  • NNZ-2591 in Angelman syndrome
  • NNZ-2591 in Pitt Hopkins syndrome
  • NNZ-2591 in Prader-Willi syndrome
• Investor Information
  • Welcome
  • Share Price Information
  • Corporate Calendar
  • Shareholder Services
  • Corporate Governance
  • Analyst Coverage
  • Corporate Directory
• News & Reports
  • ASX Announcements (All)
  • Annual and Interim Reports (All)
  • Scientific presentations (All)
  • Investor presentations, audio, video (All)
  • Email Alerts
  • Publications
• Contact Us
  • Contact Us
  • Email Alerts

• Privacy
• Site Map
• Search